comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists SGLT2 vs for CKD: Which Is Better? The cardiovascular effects of GLP-1
Description
The preclinical studies on GLP-1 receptor agonists have been comprehensively summarized in Table 2
R., Han J., et al., Effects of Exenatide (Exendin4) on Glycemic Control Over 30 Weeks in SulfonylureaTreated Patients With Type 2 Diabetes, Diabetes Care 27 (2004): 26282635
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, et al
They work best under medical supervision ideally with providers who specialize in endocrinology, obesity medicine, and long-term metabolic care
2023) have demonstrated reductions in intrahepatic fat and inflammatory markers while improving glucose homeostasis (Parker et al
